Form 4: Metagenomi CEO Brian C. Thomas Acquires Shares and Stock Options

Metagenomi's CEO, Brian C. Thomas, reports acquisition of 32,000 shares of common stock and 196,000 stock options.

Summary

• Brian C. Thomas, CEO of Metagenomi, Inc., filed a Form 4 disclosing changes in beneficial ownership.
• On April 1, 2025, Thomas acquired 32,000 shares of common stock in the form of restricted stock units (RSUs).
• These RSUs vest with 25% vesting on June 5, 2026, and the remainder vesting in 12 equal quarterly installments, contingent on continued service.
• Thomas also acquired options to purchase 196,000 shares of common stock at an exercise price of $1.32.
• 25% of these options vest on April 1, 2026, with the remainder vesting in 36 equal monthly installments, also contingent on continued service.
• Following these transactions, Thomas directly owns 2,528,276 shares of Metagenomi common stock and 196,000 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The acquisition of shares and options by the CEO could be seen as a positive sign, but it's not overwhelmingly so.

Positives

• The CEO's acquisition of shares and options could be interpreted as a positive signal, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment if interpreted as a sign of confidence from the CEO.

Key Dates

Keywords

Metagenomi, MGX, Brian C. Thomas, Form 4, Beneficial Ownership, Stock Options, Restricted Stock Units, Insider Trading